Does BELINOSTAT Cause Malignant neoplasm progression? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Malignant neoplasm progression have been filed in association with BELINOSTAT (Beleodaq). This represents 3.3% of all adverse event reports for BELINOSTAT.
10
Reports of Malignant neoplasm progression with BELINOSTAT
3.3%
of all BELINOSTAT reports
1
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BELINOSTAT?
Of the 10 reports, 1 (10.0%) resulted in death, 1 (10.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELINOSTAT. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does BELINOSTAT Cause?
Disease progression (64)
Nausea (50)
Death (40)
Vomiting (36)
Dyspnoea (31)
Anaemia (29)
Fatigue (27)
Constipation (24)
Platelet count decreased (24)
White blood cell count decreased (21)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BELINOSTAT Alternatives Have Lower Malignant neoplasm progression Risk?
BELINOSTAT vs BELUMOSUDIL
BELINOSTAT vs BELVIQ
BELINOSTAT vs BELZUTIFAN
BELINOSTAT vs BEMPEDOIC ACID
BELINOSTAT vs BEMPEDOIC ACID\EZETIMIBE